Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand M Lallemant, G Jourdain, S Le Coeur, JY Mary, N Ngo-Giang-Huong, ... New England Journal of Medicine 351 (3), 217-228, 2004 | 609 | 2004 |
Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy G Jourdain, N Ngo-Giang-Huong, S Le Coeur, C Bowonwatanuwong, ... New England Journal of Medicine 351 (3), 229-240, 2004 | 516 | 2004 |
Tenofovir versus placebo to prevent perinatal transmission of hepatitis B G Jourdain, N Ngo-Giang-Huong, L Harrison, L Decker, W Khamduang, ... New England Journal of Medicine 378 (10), 911-923, 2018 | 314 | 2018 |
Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients. P Langlade-Demoyen, N Ngo-Giang-Huong, F Ferchal, E Oksenhendler The Journal of clinical investigation 93 (3), 1293-1297, 1994 | 270 | 1994 |
Weak anti-HIV CD8+ T-cell effector activity in HIV primary infection M Dalod, M Dupuis, JC Deschemin, C Goujard, C Deveau, L Meyer, ... The Journal of clinical investigation 104 (10), 1431-1439, 1999 | 175 | 1999 |
Impact of HIV-1 genetic diversity on plasma HIV-1 RNA Quantification: usefulness of the Agence Nationale de Recherches sur le SIDA second-generation long terminal repeat-based … F Rouet, ML Chaix, E Nerrienet, N Ngo-Giang-Huong, JC Plantier, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 45 (4), 380-388, 2007 | 163 | 2007 |
CCR5 chemokine receptor variant in HIV-1 mother-to-child transmission and disease progression in children M Misrahi, JP Teglas, N N'Go, M Burgard, MJ Mayaux, C Rouzioux, ... Jama 279 (4), 277-280, 1998 | 155 | 1998 |
Combination of HIV-1-specific CD4 Th1 cell responses and IgG2 antibodies is the best predictor for persistence of long-term nonprogression V Martinez, D Costagliola, O Bonduelle, N N'go, A Schnuriger, ... Journal of Infectious Diseases 191 (12), 2053-2063, 2005 | 148 | 2005 |
Proviral HIV-1 DNA in subjects followed since primary HIV-1 infection who suppress plasma viral load after one year of highly active antiretroviral therapy N Ngo-Giang-Huong, C Deveau, I Da Silva, I Pellegrin, A Venet, M Harzic, ... Aids 15 (6), 665-673, 2001 | 144 | 2001 |
Extraordinary heterogeneity of virological outcomes in patients receiving highly antiretroviral therapy and monitored with the World Health Organization public health approach … AF Aghokeng, M Monleau, S Eymard-Duvernay, A Dagnra, D Kania, ... Clinical infectious diseases 58 (1), 99-109, 2014 | 112 | 2014 |
Early versus deferred antiretroviral therapy for children older than 1 year infected with HIV (PREDICT): a multicentre, randomised, open-label trial T Puthanakit, V Saphonn, J Ananworanich, P Kosalaraksa, ... The Lancet infectious diseases 12 (12), 933-941, 2012 | 110 | 2012 |
HIV type 1-specific IgG2 antibodies: markers of helper T cell type 1 response and prognostic marker of long-term nonprogression N Ngo-Giang-Huong, D Candotti, A Goubar, B Autran, M Maynart, ... AIDS research and human retroviruses 17 (15), 1435-1446, 2001 | 101 | 2001 |
Field evaluation of dried blood spots for routine HIV-1 viral load and drug resistance monitoring in patients receiving antiretroviral therapy in Africa and Asia M Monleau, AF Aghokeng, S Eymard-Duvernay, A Dagnra, D Kania, ... Journal of clinical microbiology 52 (2), 578-586, 2014 | 81 | 2014 |
Long-term survival of HIV-infected children receiving antiretroviral therapy in Thailand: a 5-year observational cohort study IJ Collins, G Jourdain, R Hansudewechakul, S Kanjanavanit, ... Clinical infectious diseases 51 (12), 1449-1457, 2010 | 78 | 2010 |
Prevalence of chronic hepatitis B virus infection in Thailand: a systematic review and meta-analysis C Leroi, P Adam, W Khamduang, S Kawilapat, N Ngo-Giang-Huong, ... International Journal of Infectious Diseases 51, 36-43, 2016 | 76 | 2016 |
Revisiting the role of neutralizing antibodies in mother-to-child transmission of HIV-1 F Barin, G Jourdain, S Brunet, N Ngo-Giang-Huong, S Weerawatgoompa, ... The Journal of infectious diseases 193 (11), 1504-1511, 2006 | 75 | 2006 |
Perinatal HIV Prevention Trial (Thailand) Investigators. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand M Lallemant, G Jourdain, S Le Coeur, JY Mary, N Ngo-Giang-Huong, ... N Engl J Med 351 (3), 217-228, 2004 | 69 | 2004 |
Risk factors for in utero or intrapartum mother-to-child transmission of human immunodeficiency virus type 1 in Thailand G Jourdain, JY Mary, S Le Coeur, N Ngo-Giang-Huong, P Yuthavisuthi, ... The Journal of infectious diseases 196 (11), 1629-1636, 2007 | 68 | 2007 |
Genotypic drug resistance during HIV-1 primary infection in France (1996–1999): frequency and response to treatment M Harzic, I Pellegrin, C Deveau, ML Chaix, B Dubeaux, I Garrigue, N Ngo, ... Aids 16 (5), 793-796, 2002 | 58 | 2002 |
Switching HIV treatment in adults based on CD4 count versus viral load monitoring: a randomized, non-inferiority trial in Thailand G Jourdain, S Le Cœur, N Ngo-Giang-Huong, P Traisathit, TR Cressey, ... PLoS medicine 10 (8), e1001494, 2013 | 57 | 2013 |